1. Scientists from the FDA and the National Institutes of Health are advising against one-dose regimens for Pfizer and Moderna’s COVID-19 vaccines, saying there is not available evidence to prove a single dose offers long-term protection.
2. The world needs as many as 10 billion syringes for COVID-19 vaccines, and officials in the U.S. say they currently don’t have enough, according to a March 5 report.
3. Drugmakers are exploring ways to deliver vaccines without a needle by investigating new delivery methods such as patches, dissolving implants, electrical-pulse systems, nasal sprays and pills.
4. Novartis said March 4 that it will help manufacture CureVac’s COVID-19 vaccine candidate. Merck, one of the world’s largest vaccine-makers, will work with Johnson & Johnson to boost supply of its single-shot vaccine.
5. President Joe Biden said March 2 that the U.S. is now expected to have enough COVID-19 vaccine doses for all adults by the end of May.
More articles on surgery centers:
The biggest threat to physician ownership — 3 physicians share
3 ASC leaders on adopting new technologies
The best ASCs in 25 states, ranked by Newsweek
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
